Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases

• Published in: International urology and nephrology Vol. 46; no. 7; pp. 1325 - 1328
• Main Authors: Pepe, Pietro, Fraggetta, Filippo, Galia, Antonio, Panella, Paolo, Pennisi, Michele, Colecchia, Maurizio, Aragona, Francesco
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.07.2014; Springer Nature B.V
• Subjects: Aged; Aged, 80 and over; Cystectomy; Humans; Incidental Findings; Male; Medicine; Medicine & Public Health; Middle Aged; Neoplasm Invasiveness; Neoplasms, Multiple Primary - epidemiology; Neoplasms, Multiple Primary - surgery; Nephrology; Preoperative Period; Prospective Studies; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - pathology; Urinary Bladder Neoplasms - epidemiology; Urinary Bladder Neoplasms - surgery; Urology; Urology - Original Paper; Incidental prostate cancer; Prostate cancer; Radical cystectomy; Insignificant prostate cancer
• ISSN: 0301-1623; 1573-2584
• DOI: 10.1007/s11255-014-0647-8

Purpose Preoperative findings, pathological stage PSA recurrence in patients with prostate cancer incidentally detected (iPCa) at radical cystectomy (RCP) were prospectively evaluated. Methods From July 2000 to July 2013, 242 men 71 years old (median) underwent RCP; preoperatively, all patients underwent digital rectal examination (DRE), total and free/total PSA. The bladder was totally examined; moreover, the prostate gland was step-sectioned at 4-mm intervals. The incidence of iPCa that fulfilled criteria for clinically significant iPCa was recorded: tumor volume ≥0.5 mL, Gleason grade ≥4, extracapsular extension, seminal vesicle invasion, lymph node metastasis or positive surgical margins. In the presence of iPCa, the patients underwent PSA evaluation during the follow-up and recurrence was defined as two subsequent rises >0.2 ng/mL. Results Among the 50 (20.6 %) out of 242 patients submitted to RCP, an iPCa was found and 18 (36 %) of them met criteria for insignificant iPCa; moreover, 30 % of the patients had apex involvement. Median total PSA and PSA F/T values were not significantly different in the presence versus the absence of iPCa (2.6 vs 2.7 ng/mL and 26 vs 27 %; p  > 0.05) and between significant versus insignificant iPCa ( p  > 0.05). None of the patients during the follow-up (median 58 months; range 6–102 months) had PSA recurrence. Conclusions PSA and PSA F/T values are provided for poor accuracy in distinguishing preoperatively significant from insignificant iPCa; however, the life expectancy of the patients is dramatically influenced by bladder cancer pTN (in our series, none developed PSA failure). In younger men in whom a prostate-sparing cystectomy could be proposed, an accurate preoperative evaluation should be mandatory to rule out significant iPCa at the risk of apex involvement (in our series equal to 30 % of the cases).